Volume 50, Issue 4, Pages (April 2009)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Volume 60, Issue 2, Pages (February 2014)
Volume 59, Issue 1, Pages (July 2013)
The impact of hepatitis E in the liver transplant setting
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 61, Issue 4, Pages (October 2014)
Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity”
R. Cavallo  Clinical Microbiology and Infection 
Volume 39, Issue 6, Pages (December 2003)
Volume 42, Issue 6, Pages (June 2005)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Volume 51, Issue 6, Pages (December 2009)
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Immigration and viral hepatitis
Volume 66, Issue 1, Pages 1-4 (January 2017)
Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results  Bruno Roche, Didier Samuel  Journal.
Living donor liver transplantation: is the hype over?
Reply to: “DCD consensus and futility in liver transplantation”
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Volume 68, Issue 1, Pages (January 2018)
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 68, Issue 3, Pages (March 2018)
Volume 70, Issue 1, Pages (January 2019)
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Volume 68, Issue 4, Pages (April 2018)
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Autophagy in the liver Journal of Hepatology
Volume 59, Issue 3, Pages (September 2013)
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 61, Issue 1, Pages S45-S57 (November 2014)
Stephen Locarnini, Angelos Hatzakis, Ding-Shinn Chen, Anna Lok 
Volume 42, Issue 4, Pages (April 2005)
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 67, Issue 5, Pages (November 2017)
Volume 56, Issue 6, Pages (June 2012)
Immigration and viral hepatitis
Global burden of alcoholic liver diseases
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection  Isabelle Chemin,
Volume 51, Issue 2, Pages (August 2009)
Chronic hepatitis B in children and adolescents
Volume 66, Issue 4, Pages (April 2017)
Liver transplantation in children
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Chimeric mouse model of hepatitis B virus infection
The relationship between age and fat infiltration in liver and muscle
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Volume 50, Issue 4, Pages 805-816 (April 2009) Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B  Ding-Shinn Chen  Journal of Hepatology  Volume 50, Issue 4, Pages 805-816 (April 2009) DOI: 10.1016/j.jhep.2009.01.002 Copyright © 2009 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Prevalence of hepatitis B surface antigen (HBsAg) in healthy children in Taipei from 1984 to 2004 [10]. The mass hepatitis B vaccination started in July 1984. Journal of Hepatology 2009 50, 805-816DOI: (10.1016/j.jhep.2009.01.002) Copyright © 2009 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Components of hepatitis B virus (HBV) infection and the relation to eradication of the infection. Journal of Hepatology 2009 50, 805-816DOI: (10.1016/j.jhep.2009.01.002) Copyright © 2009 European Association for the Study of the Liver Terms and Conditions